Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Limosilactobacillus Fermentum,Inapplicable
Therapeutic Area : Sleep
Study Phase : Undisclosed
Recipient : Chi-Chang Huang
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluating the Potential of Probiotic Supplementation Sleep Quality
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
July 03, 2024
Lead Product(s) : Limosilactobacillus Fermentum,Inapplicable
Therapeutic Area : Sleep
Highest Development Status : Undisclosed
Recipient : Chi-Chang Huang
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Probiotic,Inapplicable
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Recipient : National Taiwan Sport University
Deal Size : Inapplicable
Deal Type : Inapplicable
Exploring the Effects of Probiotics on Workplace Related Stress Symptoms
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
April 24, 2024
Lead Product(s) : Probiotic,Inapplicable
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Recipient : National Taiwan Sport University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : PS150,Inapplicable
Therapeutic Area : Sleep
Study Phase : Undisclosed
Recipient : National Yang Ming Chiao Tung University
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy Assessment of Probiotics in Improving Sleep Indices
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
April 11, 2024
Lead Product(s) : PS150,Inapplicable
Therapeutic Area : Sleep
Highest Development Status : Undisclosed
Recipient : National Yang Ming Chiao Tung University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Probiotic,Inapplicable
Therapeutic Area : Neurology
Study Phase : Undisclosed
Recipient : Changhua Christian Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy of Probiotics for Parkinson Disease (PD)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
November 07, 2023
Lead Product(s) : Probiotic,Inapplicable
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Recipient : Changhua Christian Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Probiotic,Inapplicable
Therapeutic Area : Musculoskeletal
Study Phase : Undisclosed
Recipient : Chi-Chang Huang
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Lactobacillus Paracasei PS23 on Improving Aging and Muscle Loss in the Elderly
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
October 02, 2023
Lead Product(s) : Probiotic,Inapplicable
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Recipient : Chi-Chang Huang
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Probiotic,Inapplicable
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Recipient : Mackay Memorial Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
April 24, 2023
Lead Product(s) : Probiotic,Inapplicable
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Recipient : Mackay Memorial Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : PS23,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Recipient : Mackay Memorial Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy of Lactobacillus Paracasei PS23 for Patients With Post-COVID-19 Syndrome
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
April 14, 2023
Lead Product(s) : PS23,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Recipient : Mackay Memorial Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactobacillus Plantarum,Inapplicable
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Psychobiotic PS128 Registration, Health Claims Approved in Thailand, Canada
Details : Lactobacillus plantarum PS128 probiotic is natural, safe way to boost mental and neural health, works from within gut to balance levels of dopamine, serotonin, and other molecules.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
June 04, 2022
Lead Product(s) : Lactobacillus Plantarum,Inapplicable
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : PS23,Inapplicable
Therapeutic Area : Musculoskeletal
Study Phase : Undisclosed
Recipient : Chi-Chang Huang
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Lactobacillus Paracasei PS23 on Anti-fatigue
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
April 26, 2022
Lead Product(s) : PS23,Inapplicable
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Recipient : Chi-Chang Huang
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : PS128,Inapplicable
Therapeutic Area : Neurology
Study Phase : Undisclosed
Recipient : Chang Gung Memorial Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Lactobacillus Plantarum PS128 in Children With ASD
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
April 01, 2022
Lead Product(s) : PS128,Inapplicable
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Recipient : Chang Gung Memorial Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable